Hardcover
This title is the first dealing with drug discovery for apicomplexan parasites, which cause prominent diseases like Malaria, Toxoplasmosis and Babesiosis. Focusing on current approaches for drug development for all apicomplexan diseases it is appealing to a large audience.
Save 7%

Apicomplexan Parasites, 1st Edition

Molecular Approaches toward Targeted Drug Development

RRP$386.04

$359.99

  • Hardcover

    550 pages

  • Release Date

    23 February 2011

Check Delivery Options

Summary

This handbook is the first dealing with the discovery of drugs directed against apicomplexan parasites. Amongst others, this group of endoparasites includes the causative agents of Malaria, Toxoplasmosis, and Babesiosis, the latter occurring mainly in animals. Written by renowned scientific experts from academia and industry, the book focuses on currentdrug development approaches for all apicomplexan diseases making it appealing to a large audience, ranging from research labs in academia to the human and veterinarian pharmaceutical industry. This work is the second volume of the new book series ‘Drug Discovery in Infectious Diseases’, edited by Prof. Dr Paul M. Selzer.

Book Details

ISBN-13:9783527327317
ISBN-10:3527327312
Author:Katja Becker, Paul M. Selzer
Publisher:Wiley-VCH Verlag GmbH
Imprint:Blackwell Verlag GmbH
Format:Hardcover
Number of Pages:550
Edition:1st
Release Date:23 February 2011
Weight:1.15kg
Dimensions:30mm x 178mm x 246mm
Series:Drug Discovery in Infectious Diseases
A-Format
B-Format
C-Format
Apicomplexan Parasites, 1st Edition by Katja Becker - ISBN: 9783527327317
178 × 246 mm
A4
mm / in
About The Author

Katja Becker

Volume editor:
Prof. Dr. Katja Becker obtained her Academic Degree in Medicine at Heidelberg University. She carried out her doctoral-thesis as well as her Habilitation at the Biochemistry Centre, Heidelberg, before she obtained a Junior Group Leader Position at the Research Center for Infectious Diseases, Wurzburg University. Since 2000 she holds the Chair of Nutritional Biochemistry at the Justus-Liebig University Giessen. Scientifically she focuses on the characterization of redox active proteins as drug targets. She has produced more than 170 scientific publications and received numerous scientific awards including the Carus Medal of the German Academy of Sciences Leopoldina and the Leuckart Medal of the German Society for Parasitology. Since June 2009 she is a member of the Leopoldina.

Series Editor:
Prof. Dr. Paul M. Selzer studied Biology, Parasitology, and Biochemistry at the University of Tubingen, Germany, where he also received his PhD in Biochemistry. He spent three years in the parasitology and tropical disease laboratory of Prof. James H. McKerrow at the University of California, San Francisco (UCSF). During his professional career he worked as researcher and scientific manager for several pharmaceutical companies, being currently employed by Intervet Innovation GmbH, Germany, part of a leading Animal Health company. Dr. Selzer is also a visiting Professor and teacher in Biochemistry, Bioinformatics, and Chemoinformatics at the University of Tubingen, and holds an Honorary Professorship in the Department of Infection and Immunity at the University of Glasgow, UK.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.